ID 1054323 - BioProject

Format

Choose Destination

Accession: PRJNA1054323 ID: 1054323

mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors

mRNA-based immunotherapeutics have garnered widespread interest for their potential to revolutionize cancer treatment. More...

Accession	PRJNA1054323
Data Type	Raw sequence reads
Scope	Multispecies
Publications	Trivedi V et al., "mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors.", Genome Med, 2024 Jan 25;16(1):17
Grants	"Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas" (Grant ID R01 CA195563, National Cancer Institute)
Submission	Registration date: 19-Dec-2023 University of Florida
Relevance	Medical

Project Data:

Parameter	Value
Data volume, Supplementary Mbytes	431

Parameter	Value
Data volume, Gbases	387
Data volume, Tbytes	0.15

Supplemental Content

maturase K, partial (chloroplast) [Kalanchoe bentii]
maturase K, partial (chloroplast) [Kalanchoe bentii]
gi|2130729744|gb|UEL36343.1|

Protein
maturase K, partial (chloroplast) [Semecarpus obovata]
maturase K, partial (chloroplast) [Semecarpus obovata]
gi|1573682886|gb|QBC73634.1|

Protein
Acanthaceae sp. 5 MIB:SASS:0429 voucher MIB:SASS 0429 5.8S ribosomal RNA gene, p...
Acanthaceae sp. 5 MIB:SASS:0429 voucher MIB:SASS 0429 5.8S ribosomal RNA gene, partial sequence; internal transcribed spacer 2, complete sequence; and large subunit ribosomal RNA gene, partial sequence
gi|2062373112|gb|MZ489780.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.